The kinetics of inhaled methyl ethyl ketone (MEK) at a concentration of 200 ppm for four hours were studied in volunteers after swallowing ethanol at a dose of 0-8 g/kg.
The inhibitory effects of acute ethanol ingestion on the liver biotransformation activities are well known.' 2 The metabolism of common industrial aromatic solvents such as toluene, m-xylene, and styrene are inhibited by ethanol taken simultaneously.'} These solvents are effectively extracted by the liver. Absorbed methyl ethyl ketone (MEK) is also extensively metabolised in man but at a clearly lower rate than aromatics." After oral9 and intraperitoneall" administration of MEK the main route of metabolism yielded 3-hydroxy-2-butanone (3H2B) and 2,3-butanediol (2,3-BD) in rats and Turku Regional Institute of Occupational Health, SF-20500 Turku, Finland J Liira K Engstrom Institute of Occupational Health, SF-00250, Helsinki V Riihimaki guinea pigs; a minor and reversible pathway produces 2-butanol.9 '°2,3-BD and 3H2B were found in the urine of subjects exposed to MEK, which supports the idea that the metabolism in man is similar to that in animals.78"' MEK is supposedly metabolised by the P450 mediated microsomal mono-oxygenase system9 known to be. influenced by the intake of ethanol. This experiment was designed to study the metabolic interactions between ethanol and MEK with special emphasis on the kinetics of MEK.
Material and methods
Five male volunteers with a mean age of 23 years (range 22-24), mean weight of 70 2 kg (range 63-77), and mean height of 180 cm (range 165-185) were studied. The mean minute ventilation at sedentary exposure was estimated to be about 11 1/min based on measurements in previous studies involving nearly similar subjects in identical conditions.'3 The subjects gave their informed consent and the principles of the Declaration of Helsinki (1964) concerning medical studies in man were strictly followed. The study was accepted by the ethical committee of the Institute of Occupational Health. No abnormalities were found during clinical examinations of the volunteers before and after the study.
The exposures to MEK were carried out in a dynamic flow exposure chamber as described in earlier studies. ' phaselayer 0-33 pm). The air samples were drawn through the walls of the aluminium foil bags immediately after the exposure with a 5 ml gas tight syringe and injected through a gas sampling valve into the chromatograph (loop volume 0 5 ml). Analyses were made at room temperature and the height of the peak was compared with a calibration curve prepared from known concentrations of MEK in bags.
Urine samples (4 ml) were sealed in 20 ml glass serum vials, kept at 60°C for two hours and the concentrations of MEK analysed by capillary gas chromatography (HP 5890, capillary column OV 101). Standards for comparison were prepared in pooled urine by adding measured amounts of MEK.
The concentrations of 2,3-BD in serum and urine were analysed using a modification of the method of Robinson and Reive.'4 One millilitre of the sample was mixed with 1 ml of acetone in an ultrasonic bath for five minutes and centrifuged for 20 minutes at 2200 rpm; 250 pl of the clear supernatant were mixed with an equal amount of n-butyl boronic acid (5 mg/ ml of acetone); and 1 pl of the derivatised sample was injected into a capillary gas chromatograph (HP 5880A, capillary column SE 54, length 25 m, ID 0-32 mm, equipped with a flame ionisation detector). The 2,3-BD isomers were separated into two peaks in the chromatograph (d-and 1-forms, and mesoform).
In calculations these two peaks were summed. The lowest detectable concentration of 2,3-BD was 2-2 pmol/l. The coefficient of variation in the paired samples was 6 4-% at a concentration of 11.1 pumol/l and 1 8 0(0 at a concentration of 111 0 pmol/l. Serum samples were analysed separately, but the urine samples of all five subjects were pooled according to the time of collection.
KINETIC CALCULATIONS
The pulmonary retention, R (0w), was calculated according to the formula R = (Cexp-Cexh)/Cexp x 100, where C,xp is the inhaled solvent concentration and CcXh is the concentration in exhaled air samples. The total pulmonary uptake, Ut (mmol), was calculated using the formula U, = (Cexp -Cexh) x V x t, where V is the minute ventilation (11 I/min) and t is the exposure time (min).
The The measurement of pulmonary retention seemed to be influenced more by variations in the breathing pattern during the collection of samples than potential changes in uptake. The measured pulmonary retentions were used in calculating total pulmonary uptake of MEK (table 1) . Although the blood concentration of MEK was increased by prior intake of ethanol as shown by the increased AUC for MEK (table 1) , no systematic effect on the total pulmonary uptake could be shown. In the morning blood ethanol concentration reflected the higher blood concentrations of MEK in the presence of ethanol.
The serum concentrations of 2,3-BD were followed up for up to eight hours after the exposure (fig 4) . In the exposure to MEK alone the serum concentration of 2,3-BD reached a maximum of Unfortunately, the follow up of the serum concentrations was stopped in the phase when 2,3-BD concentrations were still high in the combined exposures (fig 4) . The urinary excretion of 2,3-BD seemed to follow the pattern of serum concentrations of 2,3-BD and the highest excretion was detected after the exposure with previous ethanol ingestion ( fig 5) . The estimated 24 hour urinary excretion of 2,3-BD was nearly doubled in the MEK exposure with previous ethanol ingestion, whereas ethanol administration at the end of the exposure had no effect on the urinary excretion of 2,3-BD ( ferently shortly after ingestion, as compared with the a specific microsomal ethanol phase when ethanol was disappearing from the blood. zyme system has been identified. '6 Perhaps prior ethanol metabolism could interfere of ethanol (4 g/kg) inhibited the in the biodegradation of 3H2B or 2,3-BD, resulting lost aromatic and chlorinated in an increased serum concentration and urine excrelied.' In in vitro studies com-tion of 2,3-BD with exposure to MEK. These type dose dependent metabolic suggestions are, however, speculative and need to be osomal enzymes were detected confirmed.
when ethanol was given simultaneously.'
The oxidation of MEK to 3H2B, a microsomal c-l oxidation, is the rate limiting step of MEK metabolism in the rat and guinea pig,9 '°and the reaction seems to proceed only to the oxidative direction. The further reduction of 3H2B yields 2,3-BD, the known end metabolite of MEK biotransformation.9 10 In our previous studies in man with MEK less than 5% of the absorbed dose was exhaled as MEK and about 3% was excreted as 2,3-BD in the urine.78 Most of the absorbed MEK is supposedly biotransformed further by routes that have not yet been defined.
In this study ethanol effectively increased the blood concentrations of MEK and decreased the calculated clearance by about a half. The increase in the blood concentration of MEK in the combined exposure is probably caused by the inhibitory effect of ethanol on the microsomal oxidation of MEK. The reduction of MEK to 2-butanol is probably a cytosolic reaction'7 and 2-butanol is readily oxidised back to MEK, a reaction catalysed both by alcohol dehydrogenase'8 and the liver microsomal ethanol oxidising system.'9 Ethanol inhibits the alcohol dehydrogenase dependent 2-butanol oxidation in vitro. ' The blood concentration of 2-butanol was low during the exposure to MEK alone but increased 10 times after ethanol ingestion (fig 2) . The 
